Dexamethasone ophthalmic (Oculis Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDexamethasone ophthalmic (Oculis Pharma)
Drug Alias NameDexNP1.5% dexamethasone gamma-cyclodextrin nanoparticles1.5% dexamethasone γ-cyclodextrin nanoparticles1.5% dexamethasone γCD nanoparticlesDexamethasone 1.5% gamma-cyclodextrin (Oculis Pharma) +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsImmunosuppressants
TargetsGlucocorticoid receptor
Therapy Area/IndicationsDiabetic macular oedemaPain, PostoperativeInflammation +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanPuerto Rico +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesOculis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesOculis
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaMacular Edema
Inactive IndicationsPain, PostoperativeInflammationCataract +[4] 

Other Information

ATC CodeN/A
Related LinksN/A